REGN Earnings History
Regeneron Pharmaceuticals — Quarterly & Annual Financial Results
Historical Earnings Data
View Regeneron Pharmaceuticals's (REGN) complete earnings history including revenue, EPS, net income, and profit margins. Data sourced from SEC EDGAR filings and updated after every earnings report.
$3.8B
Q3 2025
$13.62
Diluted
11.6%
Growth
47
Quarterly reports
AI Forecast vs. Analyst Consensus
Wall Street Consensus
StoxPulse AI Prediction
Quarterly Earnings
| Quarter | Revenue | Net Income | EPS | Gross Margin | Net Margin |
|---|---|---|---|---|---|
| Q3 2025 | $3.8B | $1.5B | $13.62 | — | 38.9% |
| Q2 2025 | $3.7B | — | $12.81 | — | — |
| Q1 2025 | $3.0B | — | $7.27 | — | — |
| Q3 2024 | $3.4B | $1.0B |
Annual Earnings
| Year | Revenue | Gross Profit | Net Income | EPS | Op. Margin |
|---|---|---|---|---|---|
| FY 2025 | $14.3B | — | $4.5B | $41.48 | 24.9% |
| FY 2024 | $12.2B | — | $4.3B | $38.22 | 38.9% |
| FY 2023 | $16.1B | — | $8.1B | $71.97 | 55.7% |
| FY 2022 | $8.5B | — |
AI insights, news & charts
Form 4 buys & sells
Translate filings to English
Earnings for Related Healthcare Stocks
Understanding REGN Earnings Reports
Regeneron Pharmaceuticals (REGN) reports quarterly earnings in accordance with SEC regulations. Each earnings report includes the income statement (revenue, cost of goods sold, gross profit, operating income, and net income), the balance sheet, and the cash flow statement. The data shown above is sourced directly from Regeneron Pharmaceuticals's SEC filings on the EDGAR database.
Earnings Per Share (EPS) is the most closely watched metric during earnings season. Diluted EPS accounts for all potential shares from stock options and convertible securities, making it the more conservative and meaningful measure. When REGN reports EPS above the consensus analyst estimate, it's called an "earnings beat," which typically causes the stock to rise.
Profit margins reveal operational efficiency. Gross margin shows how much revenue remains after subtracting the cost of goods sold, while net margin shows the final profit after all expenses, taxes, and interest. Expanding margins often signal improving business fundamentals, while contracting margins can be a warning sign.
REGN Earnings FAQ
What were REGN's most recent earnings?
Where can I find REGN's earnings history?
What is REGN's EPS trend?
Related Tools
Disclaimer: Financial data for Regeneron Pharmaceuticals (REGN) is sourced from SEC filings and may contain processing errors. This data is provided for informational purposes only and does not constitute investment advice. Always verify data from official sources and consult a financial advisor before making investment decisions.
Get REGN Earnings Alerts
Join the waitlist to receive AI-powered earnings call summaries and financial analysis for Regeneron Pharmaceuticals within hours of every report.
Join the Waitlist